Mangoceuticals, Inc. - Common Stock
MGRX36
$2.74arrow_drop_up3.39%$0.09
Penny Stock
MGRX36
$2.74
arrow_drop_up3.39%Performance History
| Key Stats | |
|---|---|
| Open | $2.43 |
| Prev. Close | $2.50 |
| EPS | -5.70 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $6.58M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 2.39 | 2.71 |
| 52 Week Range | 0.14 | 2.71 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -5.70 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Mangoceuticals, Inc. - Common Stock (MGRX)
- Sector
- Healthcare
- Industry
- Health Information Services
- CEO
- Mr. Jacob D. Cohen
- Headquarters
- Dallas
- Employees
- 2
- Exchange
- NASDAQ
Keep an eye on Mangoceuticals, Inc. - Common Stock
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Mangoceuticals, Inc. - Common Stock's (MGRX) price per share?
The current price per share for Mangoceuticals, Inc. - Common Stock (MGRX) is $2.74. The stock has seen a price change of $0.09 recently, indicating a 3.4% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Mangoceuticals, Inc. - Common Stock (MGRX)?
For Mangoceuticals, Inc. - Common Stock (MGRX), the 52-week high is $2.75, which is 0.55% from the current price. The 52-week low is $0.14, the current price is 1.82K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Mangoceuticals, Inc. - Common Stock (MGRX) a growth stock?
Mangoceuticals, Inc. - Common Stock (MGRX) has shown an average price growth of -3.66% over the past three years. It has received a score of 97 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Mangoceuticals, Inc. - Common Stock as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Mangoceuticals, Inc. - Common Stock (MGRX) stock price performance year to date (YTD)?
As of the latest data, Mangoceuticals, Inc. - Common Stock (MGRX) has a year-to-date price change of -37.1%. Over the past month, the stock has experienced a price change of 11.38%. Over the last three months, the change has been -29.74%. Over the past six months, the figure is -55.58%.
help
Is Mangoceuticals, Inc. - Common Stock (MGRX) a profitable company?
Mangoceuticals, Inc. - Common Stock (MGRX) has a net income of -$9.21M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 58.99% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.3K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $431.5K. Operating income is noted at -$9.22M. Furthermore, the EBITDA is -$8.51M.
help
What is the market capitalization of Mangoceuticals, Inc. - Common Stock (MGRX)?
Mangoceuticals, Inc. - Common Stock (MGRX) has a market capitalization of $6.59M. The average daily trading volume is 2.7, indicating the stock's liquidity and investor engagement.
News
MANGOCEUTICALS
RESEARCH DIRECTOR
PRODUCT DEVELOPMENT
MEN'S HEALTH
Azz Inc. COO acquires $21.2k in company stock By Investing.com - Investing.com Australia
PRESS RELEASES
MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
PRESS RELEASES
MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies
PRESS RELEASES
MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts
FEATURED
PENNY STOCK BASICS
TRADING PENNY STOCKS
BEST PENNY STOCKS
LIST OF PENNY STOCKS
PENNY STOCK
PENNY STOCK NEWS
PENNY STOCKS
PENNY STOCKS TO BUY
PENNY STOCKS TO WATCH
TOP PENNY STOCKS
Spotting Penny Stocks Before They Explode, Top Tips
PRESS RELEASES
MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration